Immunosuppression

Single cell transcriptomic dissection of virus induced immunopathology in interferon gamma receptor null mice
L Yang, I Angelidis, L Heumos, M Ansari, S Zhou, C Mayr, L Simon, M Strunz, F Theis, H Adler, H Schiller

European Respiratory Journal Sep 2022, 60 (suppl 66) LSC-0036; DOI: 10.1183/13993003.congress-2022.LSC-0036
Safety of oral Nirmatrelvir plus Ritonavir in Lung transplant recipients
O Straichman, L Fridkin, I Bakal, D Shitenberg, Y Shostak, M Heching, S Amor, D Rosengarten, Y Barac, Y Peysakhovich, A Atamna, B Pertzov, M Kramer

European Respiratory Journal Sep 2022, 60 (suppl 66) 4696; DOI: 10.1183/13993003.congress-2022.4696
Critical COVID-19 Associated Pulmonary Mucormycosis (CAPM): The underreported life-threatening spectrum of the Mucormycosis epidemic
S Bansal, H Kalpakam, P Thakare, R Mehta

European Respiratory Journal Sep 2022, 60 (suppl 66) 3705; DOI: 10.1183/13993003.congress-2022.3705
Serological response following second and third SARS-CoV-2 vaccines in lung transplant recipients
E Bárczi, V Varga, A Nagy, N Eszes, Z Jáky-Kováts, V Müller, A Bohacs

European Respiratory Journal Sep 2022, 60 (suppl 66) 3859; DOI: 10.1183/13993003.congress-2022.3859
Evolution of fibrotic interstitial lung diseases (ILD) after COVID-19
M Ramos Martins, M Serino, B Martins, I Carvalho, C Valente, M Barbosa, C Cascais-Costa, M Alves, A Terras-Alexandre, N Melo, P Caetano-Mota, H Novais-Bastos, A Morais

European Respiratory Journal Sep 2022, 60 (suppl 66) 4172; DOI: 10.1183/13993003.congress-2022.4172
A retrospective cohort study to investigate the diagnostic yield of bronchoscopy with bronchoalveolar lavage in highly immunocompromised adult patients
D AlAbdulhadi, A Aljishi, G Alabbadi, M H Khalafallah, Z Almusa, R Abdulqawi

European Respiratory Journal Sep 2022, 60 (suppl 66) 3180; DOI: 10.1183/13993003.congress-2022.3180
Fungal colonisation in lung transplant recipients: A retrospective study from India
O Tisekar, M M Lalani, V Rahulan, S K Ravipati, U Shah, P Dutta, S Attawar

European Respiratory Journal Sep 2022, 60 (suppl 66) 3372; DOI: 10.1183/13993003.congress-2022.3372
Chronic hypersensitivity pneumonitis - how to predict the treatment success?
K B Lewandowska, I Baranska, M Sobiecka, P Radwan-Rohrenschef, M Dybowska, M Franczuk, A Rozy, A Skoczylas, I Bestry, J Kus, W Tomkowski, M Szturmowicz

European Respiratory Journal Sep 2022, 60 (suppl 66) 3131; DOI: 10.1183/13993003.congress-2022.3131
Microbiological profile of post covid patients admitted in tertiary care center with pulmonary infections.
D Muthreja

European Respiratory Journal Sep 2022, 60 (suppl 66) 3140; DOI: 10.1183/13993003.congress-2022.3140
Similar Programmed Death Ligand 1 expression profile in COPD and NSCLC structural and immune cells
R Esposito, D Mirra, G Spaziano, E Cione, L Gallelli, A Capuozzo, C Santoriello, M Polverino, B D'Agostino, F Polverino

European Respiratory Journal Sep 2022, 60 (suppl 66) 3466; DOI: 10.1183/13993003.congress-2022.3466

Main menu

User menu

Search

Immunosuppression

Pages

Contact us